Jean-Jacques Garaud – CEO, Inotrem, France

04.05.2019
Inotrem is a French biotech company developing a novel approach to target inflammatory diseases based on the TREM-1 pathway. Its CEO, Dr Jean-Jacques Garaud explains why he decided to leave Big Pharma for biotech, lays out Inotrem’s recent milestones, and outlines his internationalization strategy.  
The TREM-1 pathway can be used to develop treatments for different indications besides septic shock, including cardiovascular diseases and chronic inflammatory conditions, which could be interesting to investors or Big Pharma
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In
Tags:
France, Biotech, Inotrem

Related Interviews

Claire Mounier-Vehier – Cardiologist, Head of Vascular Medicine &…

Speaking exclusively to PharmaBoardroom at the International Women’s Day 2020 event at the Franco-British Chamber of Commerce in Paris, esteemed cardiologist Professor Claire Mounier-Vehier outlines why cardiovascular disease is not…

Nathalie Giraud – Director of Integrated Monitoring Investigator Services…

Nathalie Giraud, director of integrated monitoring investigator services & head of France at PPD, breaks down the strengths and weaknesses of the French clinical trials environment and stresses the importance…

Francois Cornu – President Eurofins Biomnis & Gautier Decock –…

Francois Cornu, president of Eurofins Biomnis, and Gautier Decock, managing director of Eurofins BioPharma Product Testing in France and Belgium, come together to shed light on the company’s unique decentralized…

Related Articles

Top 10 Global Pharma Markets Ranking

Based on IQVIA’s pharma market rankings for 2020, we give a rundown of the global top 10, key companies, important trends, and where you can go to learn more.  …

France / Owkin Becomes Unicorn; Sanofi/Baidu Tie-up for mRNA Algorithm; New Deals for Pierre Fabre & Abionyx

The latest news from French pharma, including AI-based biotech Owkin’s new status as a USD one billion-valued unicorn following fresh investment from Sanofi. Also included is another deal for Sanofi,…

Europe / Top 5 Countries for Pharma Production

The Top Five countries in Europe for pharma production. All located in Western Europe, Switzerland punches well above its weight to take top spot. This data is taken from the 2021…

Latest Report

InFigures Asia-Pacific 2021

Related Content

France
Biotech
Inotrem